Related references
Note: Only part of the references are listed.Cell cycle control in cancer
Helen K. Matthews et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2022)
Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation
Ruchi Sharma et al.
FRONTIERS IN NUTRITION (2022)
The Biological Activity Mechanism of Chlorogenic Acid and Its Applications in Food Industry: A Review
Liang Wang et al.
FRONTIERS IN NUTRITION (2022)
FOXM1 and Cancer: Faulty Cellular Signaling Derails Homeostasis
Dhanya Kalathil et al.
FRONTIERS IN ONCOLOGY (2021)
Chlorogenic acid inhibits proliferation in human hepatoma cells by suppressing noncanonical NF-κB signaling pathway and triggering mitochondrial apoptosis
Yanfei Jiang et al.
MOLECULAR BIOLOGY REPORTS (2021)
NRAS mutant melanoma: Towards better therapies
Tijana Randic et al.
CANCER TREATMENT REVIEWS (2021)
Advances in the discovery and development of melanoma drug therapies
Monica Chanda et al.
EXPERT OPINION ON DRUG DISCOVERY (2021)
Cutaneous Melanoma Classification: The Importance of High-Throughput Genomic Technologies
Cristian Scatena et al.
FRONTIERS IN ONCOLOGY (2021)
Aurora kinase inhibition sensitizes melanoma cells to T-cell-mediated cytotoxicity
Simone Punt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2021)
PLK1 and NOTCH Positively Correlate in Melanoma and Their Combined Inhibition Results in Synergistic Modulations of Key Melanoma Pathways
Shengqin Su et al.
MOLECULAR CANCER THERAPEUTICS (2021)
Chlorogenic acid activates ERK1/2 and inhibits proliferation of osteosarcoma cells
Luigi Sapio et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2020)
Two Natural Alkaloids Synergistically Induce Apoptosis in Breast Cancer Cells by Inhibiting STAT3 Activation
Di Chen et al.
MOLECULES (2020)
Prognostic Gene Expression Profiling in Cutaneous Melanoma Identifying the Knowledge Gaps and Assessing the Clinical Benefit
Douglas Grossman et al.
JAMA DERMATOLOGY (2020)
Overview of the Anticancer Potential of the King of Spices Piper nigrum and Its Main Constituent Piperine
Eleonora Turrini et al.
TOXINS (2020)
HI-511 overcomes melanoma drug resistance via targeting AURKB and BRAF V600E
Xiaoyu Chang et al.
THERANOSTICS (2020)
Five-Year Outcomes with Dabrafenib plus Trametinib in Metastatic Melanoma
C. Robert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The Multifaceted p21 (Cip1/Waf1/CDKN1A) in Cell Differentiation, Migration and Cancer Therapy
Nina-Naomi Kreis et al.
CANCERS (2019)
CDK2 and Bcl-xL inhibitory mechanisms by docking simulations and antitumor activity from piperine enriched supercritical extract
Valdelucia M. A. S. Grinevicius et al.
FOOD AND CHEMICAL TOXICOLOGY (2019)
Chlorogenic acid effectively treats cancers through induction of cancer cell differentiation
Shuai Huang et al.
THERANOSTICS (2019)
Oxidative Stress and Cancer: The Role of Nrf2
Soraya Sajadimajd et al.
CURRENT CANCER DRUG TARGETS (2018)
Development and evaluation of a novel drug delivery: Soluplus®/TPGS mixed micelles loaded with piperine in vitro and in vivo
Yingying Ding et al.
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY (2018)
Encorafenib plus binimetinib versus vemurafenib or encorafenib in patients with BRAF-mutant melanoma (COLUMBUS): a multicentre, open-label, randomised phase 3 trial
Reinhard Dummer et al.
LANCET ONCOLOGY (2018)
Aurora-PLK1 cascades as key signaling modules in the regulation of mitosis
Vladimir Joukov et al.
SCIENCE SIGNALING (2018)
A comprehensive review on Aurora kinase: Small molecule inhibitors and clinical trial studies
Ankit C. Borisa et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
AURKA Overexpression Is Driven by FOXM1 and MAPK/ERK Activation in Melanoma Cells Harboring BRAF or NRAS Mutations: Impact on Melanoma Prognosis and Therapy
Joan Anton Puig-Butille et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Binimetinib versus dacarbazine in patients with advanced NRAS-mutant melanoma (NEMO): a multicentre, open-label, randomised, phase 3 trial
Reinhard Dummer et al.
LANCET ONCOLOGY (2017)
Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care
Markus V. Heppt et al.
BMC CANCER (2017)
Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo
Brian D. Cholewa et al.
CANCER LETTERS (2017)
Counting on natural products for drug design
Tiago Rodrigues et al.
NATURE CHEMISTRY (2016)
Computational protein-ligand docking and virtual drug screening with the AutoDock suite
Stefano Forli et al.
NATURE PROTOCOLS (2016)
Overcoming MITF-conferred drug resistance through dual AURKA/MAPK targeting in human melanoma cells
G. Pathria et al.
CELL DEATH & DISEASE (2016)
Piperine and Derivatives: Trends in Structure-Activity Relationships
Inder Pal Singh et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Aurora B Kinase Promotes Cytokinesis by Inducing Centralspindlin Oligomers that Associate with the Plasma Membrane
Angika Basant et al.
DEVELOPMENTAL CELL (2015)
Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma
Christian Posch et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Therapy-induced tumour secretomes promote resistance and tumour progression
Anna C. Obenauf et al.
NATURE (2015)
Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations
Leanne G. Ahronian et al.
CANCER DISCOVERY (2015)
Melanoma
Dirk Schadendorf et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Induction of p21CIP1 Protein and Cell Cycle Arrest after Inhibition of Aurora B Kinase Is Attributed to Aneuploidy and Reactive Oxygen Species
Geeta Kumari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pharmacologic overview of systemic chlorogenic acid therapy on experimental wound healing
Deniz Bagdas et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Open Comet: An automated tool for comet assay image analysis
Benjamin M. Gyori et al.
REDOX BIOLOGY (2014)
Targeted therapy and immunotherapy in advanced melanoma: an evolving paradigm
Muhammad Khattak et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2013)
The DREAM complex: master coordinator of cell cycle-dependent gene expression
Subhashini Sadasivam et al.
NATURE REVIEWS CANCER (2013)
Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents
Samir A. Carvalho et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2012)
The MuvB complex sequentially recruits B-Myb and FoxM1 to promote mitotic gene expression
Subhashini Sadasivam et al.
GENES & DEVELOPMENT (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
Synthesis of piperine-amino acid ester conjugates and study of their cytotoxic activities against human cancer cell lines
V. Rama Subba Rao et al.
MEDICINAL CHEMISTRY RESEARCH (2012)
In vitro and in vivo antioxidant properties of chlorogenic acid and caffeic acid
Yuki Sato et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
Anovel Aurora-A kinase inhibitor MLN8237 induces cytotoxicity and cell-cycle arrest in multiple myeloma
Guellue Goerguen et al.
BLOOD (2010)
Signatures of mutation and selection in the cancer genome
Graham R. Bignell et al.
NATURE (2010)
Cell cycle kinases as therapeutic targets for cancer
Silvia Lapenna et al.
NATURE REVIEWS DRUG DISCOVERY (2009)
p21 in cancer: intricate networks and multiple activities
Tarek Abbas et al.
NATURE REVIEWS CANCER (2009)
Hybrid molecules with a dual mode of action: Dream or reality?
Bernard Meunier
ACCOUNTS OF CHEMICAL RESEARCH (2008)
Identification of a novel subgroup of melanomas with KIT/cyclin-dependent kinase-4 overexpression
Keiran S. M. Smalley et al.
CANCER RESEARCH (2008)
p21 and p27: roles in carcinogenesis and drug resistance
Abde M. Abukhdeir et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2008)
The BCL-2 protein family: opposing activities that mediate cell death
Richard J. Youle et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2008)
Lack of extracellular signal-regulated kinase mitogen-activated protein kinase signaling shows a new type of melanoma
Janiel M. Shields et al.
CANCER RESEARCH (2007)
Aurora-A: the maker and breaker of spindle poles
Alexis R. Barr et al.
JOURNAL OF CELL SCIENCE (2007)
Sulforhodamine B colorimetric assay for cytotoxicity screening
Vanicha Vichai et al.
NATURE PROTOCOLS (2006)
Forkhead box m1 regulates the transcriptional network of genes essential for mitotic progression and genes encoding the SCF (Skp2-Cks1) ubiquitin ligase
IC Wang et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Temozolomide for the treatment of brain metastases associated with metastatic melanoma: A phase II study
SS Agarwala et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Active cyclin B1-Cdk1 first appears on centrosomes in prophase
M Jackman et al.
NATURE CELL BIOLOGY (2003)
Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex
N Zheng et al.
NATURE (2002)
Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes
Jo Vandesompele et al.
GENOME BIOLOGY (2002)
A new mathematical model for relative quantification in real-time RT-PCR
MW Pfaffl
NUCLEIC ACIDS RESEARCH (2001)
Mitotic kinases as regulators of cell division and its checkpoints
EA Nigg
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Degradation of B-Myb by ubiquitin-mediated proteolysis:: involvement of the Cdc34-SCFp45Skp2 pathway
S Charrasse et al.
ONCOGENE (2000)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
Share Paper
